Select your language/region

News & events

Regulatory press release

2024/05/15

Changed dates for Interim Report and Annual General Meeting

Press release

2024/05/03

Q-linea applies for a NTAP code for the US market
Q-linea AB (publ) (OMX:QLINEA) today announces that the company has applied for a unique New Technology Add-on Payment (NTAP)...
Read more >

Press release

2024/05/02

Q-linea signs evaluation contract with reference laboratory network in the US
Q-linea AB (publ) (OMX:QLINEA) today announces that the company has signed an evaluation contract with a large network reference...
Read more >

Regulatory press release

2024/04/26

Q-linea receives US FDA 510(k) clearance for the ASTar® System
Q-linea AB (publ) (OMX:QLINEA) today announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance...
Read more >

Presentations

2024/04/19

Life Science Day 2024

Regulatory press release

2024/04/12

Q-linea publish the Annual report for 2023
Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), announced today that the Annual Report for the 2023 fiscal year has been...
Read more >

Presentations

2024/03/18

Redeye Theme: Commercialization in Life Science on March 20, 2024

Press release

2024/03/13

Strong ASTar results presented at AMCLI

Press release

2024/03/05

Q-linea participates in tender for rapid AST

Load more